[M&A Reboot] Fujifilm’s Original Business, Photographic Film, Now Less Than 1% of Sales; Transformation into Healthcare and Semiconductor Materials Company – M&A Online

News Highlights

Fujifilm has drastically shifted its business structure, reducing the sales ratio of its original photographic film business to less than 1%, and transforming into the healthcare and semiconductor materials fields. Through M&A and business restructuring, the company has successfully pivoted to growth areas. This case suggests that, just as the photographic film business declined, certain medical departments or businesses may shrink in the future for medical institutions, highlighting the importance of business succession and M&A for management strategy.

M&A Medical Editorial Department’s Perspective

Fujifilm’s transformation serves as a prime example for healthcare institution managers, underscoring the risks of clinging to one’s original business. Just as photographic film, once a core business, became less than 1% of sales due to digitalization, it cannot be denied that certain medical departments or services may become obsolete in the future. Just as Fujifilm pivoted to healthcare and semiconductor materials through M&A and new business investments, medical institutions should also consider expanding into new revenue streams and implementing M&A strategies to achieve this, looking ahead to changes in regional healthcare and technological innovation, rather than solely strengthening existing businesses. In particular, the path for community-based hospitals to build a sustainable management foundation by collaborating and integrating with highly specialized clinics and nursing care facilities shares common ground with Fujifilm’s business restructuring strategy.

Points This News Highlights

• Fujifilm’s business portfolio transformation suggests the necessity of “selection and concentration” for medical institutions.
• A warning against the potential future management risk of clinging to original or existing businesses.
• Bold allocation of management resources to growth areas through M&A and new business investments is key to success.
• The importance of strategic business succession and integration, looking towards the future of regional healthcare.

Practical Questions Arising from This News

• Just as the photographic film business declined, is it possible that our hospital’s main medical departments will see reduced demand in the future?
• Like Fujifilm, what fields can be considered for securing new revenue streams through M&A?
• When considering business succession, how should we leverage our institution’s strengths while expanding into future-oriented fields?

If You Feel “Should I Consult?”

In envisioning your institution’s future, are there possibilities that your current business structure poses future risks? It may be time to consider, with experts, options for creating new value in regional healthcare and building a sustainable management foundation through M&A and business restructuring, much like Fujifilm. Especially if you are concerned about a lack of successors or declining profitability in existing businesses, early consultation will broaden your future options.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as an M&A support institution certified by the Small and Medium Enterprise Agency, with a full success fee basis. We handle consultations with strict confidentiality. Free consultations are available here.